Abstract
25-Acetyl-petrosaspongiolide M (PMAc) (1), a mild non-covalent PLA(2) inhibitor, unexpectedly recovers, after incubation with bvPLA(2), the ability to covalently modify the enzyme target. This study demonstrates the catalytic effect of bvPLA(2) in converting 1 in its deacetylated congener petrosaspongiolide M (PM) (2), a strong covalent PLA(2) inhibitor whose molecular mechanism of inhibition has already been clarified. Moreover, our findings outline the potential role of PMAc as anti-inflammatory pro-drug, by virtue of its ability of delivering the active PM agent at the site of inflammation, functioning as a suicide inhibitor.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylation
-
Animals
-
Binding Sites
-
Catalysis
-
Chromatography, High Pressure Liquid
-
Circular Dichroism
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology*
-
Group II Phospholipases A2
-
Hydrogen-Ion Concentration
-
Hydrolysis
-
Kinetics
-
Ligands
-
Mass Spectrometry
-
Molecular Structure
-
Molecular Weight
-
Oleanolic Acid / analogs & derivatives*
-
Oleanolic Acid / chemistry
-
Oleanolic Acid / pharmacology*
-
Phospholipases A / metabolism*
-
Phospholipases A2
-
Porifera / chemistry
-
Protein Conformation
-
Protein Structure, Secondary
-
Spectrometry, Mass, Electrospray Ionization
-
Temperature
Substances
-
Enzyme Inhibitors
-
Ligands
-
petrosaspongiolide m
-
Oleanolic Acid
-
Phospholipases A
-
Group II Phospholipases A2
-
Phospholipases A2